|
Dr. Baenziger is a medical doctor trained at the University of Basel in Basel, Switzerland and has a Doctorate in Medicinal Biochemistry. He has held biotechnology investment positions with the international investment banks Lombard, Odier & Cie in Zurich and Deutsche Morgan Grenfell in New York. He has significant marketing and strategic development experience from his tenure at international conglomerate giant Nestlé corporation in Switzerland, France and Germany. Recently, he was the Managing Director of the Swiss National Competence Centre of Research in Nanoscience overseeing 240 researchers. Currently, Dr. Baenziger is the founder and CEO of Nexatio Pharmaceuticals in Basel, Switzerland, a private biotechnology company focused on targeted cancer therapies that has demonstrated positive clinical results in compassionate-use trials with its therapy for malignant glioma. | 